###begin article-title 0
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas
###end article-title 0
###begin p 1
Conceived and designed the experiments: MB AI KHX JYD MS OD. Performed the experiments: MB PYC BB YM EC. Analyzed the data: MB PYC BB YM EC. Wrote the paper: MB OD.
###end p 1
###begin p 2
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 389 395 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 862 868 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1011 1017 1011 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1056 1062 1056 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1165 1171 1165 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
The combined deletion of 1p and 19q chromosomal arms is frequent in oligodendrogliomas (OD) and has recently been shown to be mediated by an unbalanced t(1;19) translocation. Recent studies of 1p/19q co-deleted OD suggest that the NOTCH2 gene is implicated in oligodendrocyte differentiation and may be involved in this rearrangement. The objective of the present study was to analyze the NOTCH2 locus either as a chromosomal translocation locus that may be altered by the 1p/19q recurrent rearrangement or as a gene that may be inactivated by a two hit process. We performed an array-CGH analysis of 15 ODs presenting 1p/19q co-deletion using a high-density oligonucleotide microarray spanning 1p and 19q pericentromeric regions with 377 bp average probe spacing. We showed that the 1p deletion extends to the centromere of chromosome 1 and includes the entire NOTCH2 gene. No internal rearrangement of this gene was observed. This strongly suggests that the t(1;19) translocation does not lead to an abnormal NOTCH2 structure. The analysis of the entire NOTCH2 coding sequence was performed in four cases and did not reveal any mutation therefore indicating that NOTCH2 does not harbor genetic characteristics of a tumor suppressor gene. Finally, the detailed analysis of chromosome 19 pericentromeric region led to the identification of two breakpoint clusters at 19p12 and 19q11-12. Interestingly, these two regions share a large stretch of homology. Together with previous observations of similarities between chromosome 1 and 19 alphoid sequences, this suggests that the t(1;19) translocation arises from complex intra and interchromosomal rearrangements.
###end p 2
###begin p 3
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
This is the first comprehensive deletion mapping by high density oligo-array of the 1p/19q co-deletion in oligodendroglioma tumors using a methodological approach superior to others previously applied. As such this paper provides clear evidence that the NOTCH2 gene is not physically rearranged by t(1;19) translocation of oligodendroglioma tumors.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 116 119 116 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Kitange1">[1]</xref>
###xml 120 123 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-HoangXuan1">[6]</xref>
###xml 246 249 246 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Jeuken1">[7]</xref>
###xml 250 253 250 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Reifenberger1">[9]</xref>
###xml 321 324 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Bigner1">[3]</xref>
###xml 599 602 599 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Cairncross1">[4]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Smith2">[10]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih1">[11]</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Abrey1">[12]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih2">[13]</xref>
###xml 1283 1287 1283 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Jenkins1">[14]</xref>
###xml 1307 1311 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Griffin1">[15]</xref>
###xml 1528 1532 1528 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih2">[13]</xref>
###xml 1534 1538 1534 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Boulay1">[16]</xref>
###xml 1627 1633 1627 1633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1694 1698 1694 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Hu1">[17]</xref>
###xml 1727 1731 1727 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Fan1">[18]</xref>
###xml 406 414 <span type="species:ncbi:9606">patients</span>
###xml 725 730 <span type="species:ncbi:9606">human</span>
Concurrent deletion of chromosomal arms 1p and 19q is the most common genetic alteration in oligodendroglial tumors [1]-[6]. Indeed, it is detected in 50% to 80% of oligodendroglial tumors including oligodendrogliomas (ODs) and oligoastrocytomas [7]-[9]. In contrast 1p/19q codeletion is uncommon in diffuse astrocytomas [3]. Combined 1p/19q allelic loss is observed in both grade II and grade III ODs. In patients affected with oligodendroglioma this genotype is associated with increased progression-free and overall survival as well as a better responsiveness to durable response to chemotherapy [4], [10], [11], [12]. We have previously constructed a 1 Mb resolution BAC array containing 3342 genomic clones covering the human genome and applied it to profile DNA copy number alterations of an extended series of 112 gliomas, including 49 ODs [13]. In the course of this study, we observed the presence of a consistent chromosome 1 breakpoint in the vicinity of the centromere in tumors presenting 1p/19q allelic loss. Based on this observation, we hypothesized that the break itself rather than the deletion might play a role in tumor development, supporting therefore the presence of a t(1;19) translocation. This hypothesis was further reinforced by studies of Jenkins et al. [14] and Griffin et al. [15] showing that an unbalanced t(1;19)(q10;p10) translocation accounts for the 1p/19q pattern and that this combined co-deletion results from the loss of one of the two translocation derivatives. Moreover, we and others [13], [16] found that 1p juxta-centromeric deletion breakpoints map within the region encoding the NOTCH2 gene which is implicated in oligodendrocyte differentiation [17] and brain tumor oncogenesis [18].
###end p 5
###begin p 6
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 629 635 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
NOTCH2 constitutes a very attractive candidate to be specifically rearranged by the t(1;19) translocation. Rearrangement could lead to the formation of a fusion gene or to truncation of the gene. To more thoroughly investigate the NOTCH2 region we constructed a high density, locus-specific oligonucleotide array-CGH covering the entire 1p pericentromeric region and applied it to profile 11 ODs with 1p/19q co-deletion. The chromosome 19 pericentromeric region was also investigated using the same approach. Finally, in order to further evaluate a potential tumor suppressor genetic model we searched for point mutations of the NOTCH2 gene in four of our OD cases.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
NOTCH2 as a candidate target of the pericentromeric t(1;19) translocation in oligodendrogliomas
###end title 8
###begin p 9
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g001">Figure 1</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih2">[13]</xref>
###xml 300 308 300 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g001">Figure 1</xref>
###xml 734 740 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 915 921 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g001">Figure 1B</xref>
###xml 1187 1193 1187 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1228 1231 1228 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N2N</italic>
###xml 1459 1463 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Locke1">[19]</xref>
###xml 1581 1587 1581 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1380 1385 <span type="species:ncbi:9606">human</span>
Figure 1 displays chromosome 1 BAC-array results for two ODs DNAs, representative of the series of 49 ODs previously described [13]. In all cases, decreased tumor/normal fluorescence ratios, indicative of a deletion in the tumor DNA, were detected starting from BAC RP11-323K8 to the telomere of 1p (Figure 1). Conversely, normal fluorescence ratios were observed from BAC RP11-114O18 to the telomere of 1q. These results strongly suggested that a recurrent chromosome breakpoint, lying between BAC RP11-323K8 and BAC RP11-114O18 mapping at physical position 120,191,966-120,379,651 and 120,191,966-120,379,651 on chromosome 1, was a characteristic feature of ODs with 1p/19q co-deletion. Intriguingly, this region is included within NOTCH2. Given that the 1p/19q co-deletion pattern has been recently linked to a t(1;19) chromosome translocation, this suggested that the chromosome 1 breakpoint may lie within the NOTCH2 gene. However, this putative breakpoint coincides with a transition from a single copy region (BAC RP11-323K8) to a segmental duplication (BAC RP11-114O18). Indeed, the sequence of this last BAC is duplicated at 1q21.1 (Figure 1B) which encodes a truncated copy of NOTCH2, NOTCH homolog 2 N-terminal like (N2N). Unlike common repeats (e.g. Alu or long interspersed nuclear elements (LINEs), the duplicated sequences in BAC clones resist complete blocking by human Cot-1 DNA, specifically when duplications are large and highly identical [19]. Therefore we could not conclude from these experiments whether the chromosome 1 breakpoint was localized within the NOTCH2 gene or whether the apparent position of this break was falsely attributed to the presence of a segmental duplication.
###end p 9
###begin title 10
Detection of chromosome 1p recurrent deletions in oligodendrogliomas using 1 Mb BAC array-CGH.
###end title 10
###begin p 11
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g001">figure 1B</xref>
###xml 973 979 973 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
The vertical line denotes the centromere of chromosome (centr). The X-axis displays the physical position on chromosome 1 in megabases. A position landmark is indicated every 50 BACs. The Y-axis denotes the average normalized fluorescence ratio (ratio of means for the intensities between test/tumor and reference/normal DNA). (A) Array-CGH profiles illustrating 1p deletion in two selected oligodendrogliomas (OD16 and OD839) presenting 1p/19q co-deletion pattern. The box centers on the centromere and pericentromeric region shown in figure 1B. (B) Detailed view of 181 Kb recurrent deletion breakpoint segment. The blue diamonds highlight the supplementary clones in the improved version of a 1 Mb BAC array used in this analysis. Black arrows above the genes show the orientation of their transcription. The position of the distal end of each BAC is indicated. The lower part of the figure shows an enlargement of the box with indication of BAC clones (open bars), the NOTCH2 gene (black bar) and segmental duplications (Dupl, orange bar).
###end p 11
###begin title 12
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
Exclusion of NOTCH2 as candidate target of t(1p;19q) translocation-high density loci-specific oligonucleotide array
###end title 12
###begin p 13
###xml 307 315 <span type="species:ncbi:9606">patients</span>
###xml 398 405 <span type="species:ncbi:9606">patient</span>
To investigate in depth the putative breakpoint regions we constructed a high density, oligonucleotide probes-based array (Agilent Technologies) providing high resolution over the pericentromeric regions of chromosome arms 1p and 19q. This loci-specific array was applied to profile OD DNAs derived from 15 patients. Each tumor DNA was paired with corresponding peripheral blood-derived DNA of the patient and with normal male DNA in individual experiments (used as references).
###end p 13
###begin p 14
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 192 201 192 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">Figure 2A</xref>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 591 604 591 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">Figure 2A, 2B</xref>
###xml 998 1007 998 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">figure 2B</xref>
###xml 1013 1019 1013 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1400 1406 1400 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1664 1673 1664 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">Figure 2A</xref>
###xml 1774 1780 1774 1780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1833 1842 1833 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">Figure 2C</xref>
###xml 1906 1912 1906 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 2041 2054 2041 2054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">Figure 2C, 2D</xref>
###xml 2332 2338 2332 2338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 2426 2432 2426 2432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 2476 2493 2476 2493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">Figures 2E and 2F</xref>
###xml 2544 2545 2544 2545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 2551 2552 2551 2552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 2569 2575 2569 2575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 2583 2584 2583 2584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 2589 2590 2589 2590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 2818 2824 2818 2824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1586 1591 <span type="species:ncbi:9606">human</span>
The 1.8 Mb synthesized 1p pericentromeric-specific region consisted of 4262 measurement points of varying repeat/duplication content including 478 probes covering the NOTCH2 gene. As shown in Figure 2A the general distribution of aberrations defined by this high-resolution array supported the existence of 1p deletion in all studied cases. This figure displays output from the analysis of a representative case, illustrating a contiguous 165 kb region, telomeric to NOTCH2 gene, (chromosome 1p position 119,457,515-119,622,059) covered by 500 probes. The probes fall into two major groups (Figure 2A, 2B). The first group mainly includes single copy probes, as assessed by a single hit through whole-genome BLAT analysis and indicated by red diamonds on the figure, which display average log2 fluorescence ratios close to -1 corresponding to a deletion profile. The second group exhibits normal (close to 0) log2 fluorescence ratios and mostly contains probes with multiple BLAT hits. As shown in figure 2B, the NOTCH2 region can be divided in two segments. The 3' part contains numerous single copy probes and presents a clear deleted profile whereas the 5' duplicated end shows normal log2 ratios. These oligonucleotide array results are in perfect agreements with the BAC array data described above showing convergence of the apparent distal breakpoint of the deletion with the starting point of NOTCH2 intrachromosomal duplication. In order to define reliable copy number changes we selected the probes for which the BLAT search displayed only a single chromosomal position within human genome with 100% sequence identity (probes indicated by red diamonds in Figure 2A). As a result, a group of 851 unique probes on chromosome 1, including 128 data points covering the NOTCH2 gene, was extracted and is visualized on the graph (Figure 2C). Strikingly, 16 unique data points located centromeric of the NOTCH2 gene enclosed by the chromosomal position 120,874,063-121,032,434 clearly indicated consistently decreased fluorescence ratios (Figure 2C, 2D) in all studied cases. To confirm that the deletion extended to the centromere, we further performed LOH-associated SNP loci analysis on five selected 1p/19q oligodendroglioma cases using a panel of 39 single copy SNP (single-nucleotide polymorphisms) markers encompassing the NOTCH2 locus. This analysis showed that informative SNPs, being proximal, within or distal to NOTCH2 exhibited loss-of-heterozygosity profiles. Figures 2E and 2F show representative results for SNPs intragenic (Ea and Eb) or proximal to NOTCH2 part (Fc to Fg). All above outlined results, therefore, confirmed the presence of continuous 1p deletions extending all the way to the centromere and consequently ruled out the chromosome 1 translocation breakpoint being localized within the NOTCH2 gene.
###end p 14
###begin title 15
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
Deletion extends centromeric to NOTCH2 as revealed by the high density oligonucleotide array.
###end title 15
###begin p 16
###xml 330 336 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 904 910 904 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 984 990 984 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1053 1059 1053 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1387 1393 1387 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1570 1576 1570 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1683 1689 1683 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1857 1863 1857 1863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 2132 2138 2132 2138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 2235 2236 2235 2236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 2243 2244 2243 2244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 2329 2335 2329 2335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 2387 2388 2387 2388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 2489 2495 2489 2495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 322 329 <span type="species:ncbi:9606">patient</span>
###xml 488 495 <span type="species:ncbi:9606">patient</span>
###xml 714 719 <span type="species:ncbi:9606">human</span>
###xml 2222 2229 <span type="species:ncbi:9606">patient</span>
The X-axis displays the oligonucleotide probe order according to their physical position on chromosome 1 in megabases. A position landmark is indicated every 100 probes. The Y-axis denotes the average normalized fluorescence ratios on a log2 scale. Black diamonds represent the normalized log2 ratio from hybridization of patient versus reference (normal male) peripheral blood-derived DNAs, used as control experiment. The blue and pink diamonds illustrate normalized log2 ratios of the patient tumor DNA to the reference or to the matched peripheral blood-derived DNAs, respectively. The red diamonds above the graphs indicate the probes for which BLAT search displayed only a single chromosomal position within human genome with 100% sequence identity. (A) log2 ratio plot of a representative oligodendroglioma DNA (OD1786) displaying 500 oligonucleotide probes (119,457,515-119,619,961) telomeric to NOTCH2 gene. (B) Array-CGH profile of OD1786 displaying probes encompassing the NOTCH2 gene. The positions of the 34 exons (black horizontal bar) of NOTCH2 and the segmental duplication (Dupl; orange horizontal bar) are highlighted above the array-CGH profile. Probes located within segmental duplication loci displayed quasi-normal fluorescence ratio, consistent with the duplication of this region to 1q21.1. (C) A pool of 851 single hit probes, including 128 data points covering NOTCH2 gene is visualized. The majority of the probes displayed an average fluorescence ratio close to -1 (haploid level), consistent with the presence of a deletion. The position of NOTCH2 gene is indicated by a black horizontal bar. The black box (D) highlights deletion of loci centromeric to NOTCH2. (D) Enlarged, detailed view of the normalized fluorescence log2 ratio for 16 unique loci enclosed by the chromosomal position 120,874,063-121,032,434, centromeric to NOTCH2. The X-axis displays every unique probe according to its physical position on chromosome 1. The vertical arrows indicate the position of the selected LOH (loss of heterozygosity)-associated SNP (single nucleotide polymorphism) loci analyzed. (E) LOH at loci distal to NOTCH2. Sequencing data comparing SNPs constitutional (B) and tumor DNA (T) from the same patient. In (a) and (b) examples of SNPs (rs1923929 and rs2453042, respectively) located within segment of NOTCH2 gene. (F) Detection of LOH within five SNP loci (c-g) (rs2319971, rs10903156, rs12743661 rs28785495 and rs28793055, respectively) located centromeric to NOTCH2 gene.
###end p 16
###begin title 17
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
Mutation analysis of the NOTCH2 gene sequence
###end title 17
###begin p 18
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
An hypothesis which may account for the localization of the t(1;19) translocation breakpoint proximal to NOTCH2 may rely on a two-hit inactivation process with one allele of NOTCH2 being inactivated by the deletion and the remaining one by point mutation. To test this hypothesis, we screened for somatic mutations the complete coding sequence of NOTCH2 gene in four tumor and paired peripheral blood derived DNAs. The 34 exon sequences of this gene transcript span 9371 bp and encode a protein of 2555 amino acids. Sequence analyses of these genomic DNAs revealed no heterozygous mutation in either of the NOTCH2 exons (data not shown).
###end p 18
###begin title 19
Two clusters of translocation breakpoints on chromosome 19
###end title 19
###begin p 20
###xml 59 68 59 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g003">Figure 3A</xref>
###xml 888 897 888 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g003">Figure 3B</xref>
###xml 1037 1046 1037 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g003">Figure 3C</xref>
###xml 1184 1193 1184 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g003">Figure 3D</xref>
###xml 1281 1294 1281 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g003">Figure 3E, 3F</xref>
###xml 1352 1360 1352 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004107.s001">Table S1</xref>
###xml 1556 1572 1556 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g003">figure 3E and 3F</xref>
###xml 1920 1933 1920 1933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g003">Figure 3E, 3F</xref>
As outlined above, the hemizygous deletion of the 19q arm (Figure 3A) strongly associates with 1p single copy loss, both events being mediated by a t(1;19) translocation with juxta-centromeric breakpoints. Therefore, we applied a chromosome 19 pericentromeric high density genomic microarray to precisely detect putative breakpoint sites. This array resolves the pericentromeric region of 1.4 Mb (positions on chromosome 19 23,940,099-24,422,759 and 32,426,023-33,387,097; build 36.1) into 3417 distinct measurement points with an average probe spacing of 379 bp. This 19q specific array proved to be a sensitive assay for detecting deletion of the 19q. In the course of these analyses three types of profile were retrieved. The first type consisted of a complete deletion of the 19q analyzed region extending down to chromosome 19p pericentromeric region. It was observed in 5/15 cases (Figure 3B). The second type, observed in 6/15 cases, was characterized by a transition from normal to deleted ratios within the analyzed 19q region (Figure 3C). The third class of profile, detected in 4 cases, revealed the coexistence of 19q loss with different patterns of gains/amplifications (Figure 3D). The positions of the breakpoints were slightly different from one case to the other (Figure 3E, 3F, for breakpoint positions information, see supplementary Table S1) and defined one major breakpoint cluster in 19p and another one on 19q. The 19p and 19q regions were determined to be 5 kb and 157 kb in size, respectively. The two cluster regions are shown on figure 3E and 3F. Using publicly available databases we reviewed the genes present in these regions and observed that only in the 19q region are there annotated gene sequences; namely the non-RefSeq transcripts AK075337, AK094188, AK055559, BC024732 and DQ586608. Both regions are also known to be encompassed by putative copy number polymorphism variation (CNP) (Figure 3E, 3F); however we did not find variation of these fragments in any of 15-germline DNA samples.
###end p 20
###begin title 21
Array-CGH profiles of the representative cases containing deletions affecting chromosome 19.
###end title 21
###begin p 22
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g001">Figure 1</xref>
###xml 571 579 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004107-g002">Figure 2</xref>
(A) Detection of deletion of the long arm of chromosome 19 using 1 Mb BAC array-CGH. The general outline of this figure follows Figure 1. The blue diamonds highlight the supplementary clones in the improved version of a 1 Mb BAC array used in this analysis. (B and C) Array-CGH profiles of two representative tumors disclosing the presence of continuous 19q deletion extending to: 19p (3B, OD1778) and 19q pericentromeric regions (3C, OD758). The positions of translocation breakpoints are highlighted by black boxes (E and F). The general outline of the figures follows Figure 2. (D) An example of oligodendroglioma case (OD1216) disclosing a gain which precedes 19q allelic loss. The positions of the breaks are highlighted by the black boxes (E and F). (E and F) Schematic representation of chromosome 19 breakpoint regions mapping at positions 24,172,000-24,177,100 and 32,800,000-33,000,000 within pericentromeric regions of chromosome 19. The oligonucleotide probes (vertical dark bars) are indicated according to their physical position on chromosome 19. The numbers of cases (Nr of cases) which display breakpoints are indicated. The cases displaying regional gain/amplifications are marked with an asterisk. The non-RefSeq transcripts (brown horizontal bar) and putative copy number polymorphisms (CNP) (gray horizontal bar) are drawn to scale.
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih2">[13]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Griffin1">[15]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Jenkins1">[14]</xref>
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Gregory1">[20]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-She1">[22]</xref>
###xml 872 875 872 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Smith1">[2]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Smith2">[10]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Barbashina1">[23]</xref>
###xml 889 893 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Nigro1">[24]</xref>
###xml 1035 1041 1035 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1317 1323 1317 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1404 1410 1404 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1472 1478 1472 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 1646 1652 1646 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 559 564 <span type="species:ncbi:9606">human</span>
###xml 1098 1103 <span type="species:ncbi:9606">human</span>
Our study follows up previous works that identified the existence of a nearly consistent deletion hotspot within pericentromeric region of 1p in ODs with 1p/19q allelic loss [13]. Interestingly, recent observations by Griffin et al. [15] and Jenkins et al. [14] also support the presence of a 1;19 translocation accompanied by a loss of one of the two translocation derivatives. The fact that NOTCH2 is located near the chromosome 1 centromere made analysis of this interval a considerable challenge. Pericentromeres are among the most complex regions within human genome and contain several inter- and intra-chromosomal duplications and repeat sequences which increase in number when approaching the centromere [20]-[22]. The high density oligonucleotide array-CGH we applied is superior to previous methodological approaches used in the analysis of 1p/19q co-deleted OD [2], [10], [23], [24] with the major advantage being the high resolution of analysis due to the large number of independent measurement points completely covering NOTCH2 gene and extending to the most centromeric point on the human reference sequence. We found that deletion on chromosomal arm 1p is in fact continuous and that its endpoint apparently lies within the centromere. Moreover, an additional detailed mutation analysis of all coding NOTCH2 exons in four 1p/19q codeleted ODs presenting LOH showed no evidence of somatic NOTCH2 mutations. This indicates that the deletion of one allele of NOTCH2 is not associated with mutation of the other allele. Although haploinsufficiency and/or further genetic and epigenetic changes remain to be tested this indicates that NOTCH2 does not present genetic characteristic of a tumor suppressor gene.
###end p 24
###begin p 25
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 1027 1031 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Grimwood1">[21]</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Baldini1">[25]</xref>
###xml 1439 1443 1439 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Gravholt1">[26]</xref>
###xml 1444 1448 1444 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Blanco1">[28]</xref>
###xml 2043 2047 2043 2047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-AlTaie1">[29]</xref>
###xml 2856 2860 2856 2860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Ehrlich1">[30]</xref>
###xml 2861 2865 2861 2865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Ehrlich2">[36]</xref>
###xml 302 307 <span type="species:ncbi:9606">human</span>
###xml 333 360 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 427 432 <span type="species:ncbi:9606">human</span>
On chromosome 19 the high-resolution array-CGH analysis identified pericentromeric breakpoints in most cases. In silico study of 19q contrary to 19p pericentromeric region revealed the presence of highly repetitive architecture with multiple various classes of low copy repeat sequences such as Alpha, human satellite IV (HSAT4) and human endogenous retrovirus (HERVK) repeats at breakpoint sites (not shown). BLAT analysis of human sequence assembly showed intra- and interchromosomal sequence similarity of this locus. In particular it highlighted a high sequence homology between the two chromosome 19 cluster regions over a more than 50 kb stretch. We may therefore speculate that chromosome 19 pericentromeric loci comprise specific recombination-prone genomic structures leading to chromosomal instability by recombination-driven rearrangements. Importantly, strong DNA sequence homology of chromosome 19 to chromosome 1 centromeric and pericentromeric regions with several common alpha-satellite sequences was described [21], [25]. This suggests that the specific architecture of these segments might be more prone to chromosomal rearrangements, thus mediating chromosome breakage and generating the aforementioned 1p/19q translocation. Alphoid repeats have already been documented in some derivatives of the recurrent translocations suggesting genomic instability as a cause of arm-to-arm translocations in several types of tumors [26]-[28]. We cannot exclude other mechanisms that may be responsible for the profiles revealed by the array-CGH analysis of these 1p/19q co-deleted cases. Indeed, copy number polymorphisms encompassing the chromosome 19 breakpoint regions suggesting that some alternative structure of these regions may favor 1p/19q recurrent rearrangement in OD cases. It has been shown, for example, that complex repeat structures with functionally relevant polymorphism not only presents functional relevance to promoter activity but also demonstrate genetic instability in colorectal tumors of the mutator phenotype [29]. However, the peripheral blood versus reference DNA CGH experiments that were conducted as control experiments in our work did not identify obvious copy number variations. Finally, cancer-specific 1p/19q translocation might be facilitated by general genomic instability associated with alterations of the pericentromeric chromatin structure by epigenetic perturbation. Evidence suggests that the hypomethylation process induces pericentromeric heterochromatin decondensation and contributes to the instability of the satellite DNA sequences. This may permit recombination and formation of unstable translocations. Such decondensation has been described in glioblastoma as well as in other type of tumors such as facial anomalies syndrome, multiple myeloma, hepatocellular carcinomas, breast and Wilms tumors [30]-[36].
###end p 25
###begin p 26
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
The data presented here revealed that chromosome 1 and 19 status in the tumors displaying t(1;19) recurrent translocations is more complex than previously thought. In summary, we exclude NOTCH2 gene as a target of apparent translocation breakpoint and suggest involvement of the centromere and centromere/pericentromere sequences of chromosome 1 and 19, respectively, in the process of translocation. We also reveal novel pericentromeric breakpoint sites on 19p and 19q arms.
###end p 26
###begin title 27
Materials and Methods
###end title 27
###begin title 28
Clinical material
###end title 28
###begin p 29
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih2">[13]</xref>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
The current study consisted of oligodendroglioma tumor samples treated at the Pitie-Salpetriere hospital, Paris, France and previously shown to harbor 1p/19q co-deletion [13]. Tumor samples were snap-frozen and stored at -80degreesC immediately after surgical resection. High molecular weight DNA was isolated from both tumor and peripheral blood using a standard phenol-chloroform procedure. All patients gave written informed consent, as requested by French law, allowing molecular, genetic and translational research studies on cancer tissue samples. The analysis was performed on anonymized data.
###end p 29
###begin title 30
1 Mb genomic BAC ARRAY-CGH platform
###end title 30
###begin p 31
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih1">[11]</xref>
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004107-Idbaih2">[13]</xref>
A full-coverage genomic BAC aCGH with an average resolution of 1 Mb, previously described [11], was used for DNA copy number analysis. In particular, it contains a set of 402 measurement points localized on 1p, as well as 41 chromosome loci confined to chromosome 19. In order to increase the resolution of analysis an additional twenty-five BAC clones in the vicinity of the chromosome 1 centromere were further selected for inclusion on the initial 1 Mb array. The procedures for DNAs extraction, hybridization and washing have been described previously [13]. Arrays were scanned using a 4000B scan (Axon, Union city, USA). Image analysis was performed with Genepix 5.1 software (Axon, Union city, USA) and ratios of Cy5/Cy3 signals were determined.
###end p 31
###begin title 32
High density oligonucleotide array-CGH platform
###end title 32
###begin p 33
###xml 621 627 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 332 337 <span type="species:ncbi:9606">human</span>
###xml 796 801 <span type="species:ncbi:9606">human</span>
The Agilent eArray platform was used to design oligonucleotide array-CGH (8x15 K, Agilent Technologies, Palo Alto, CA) providing high resolution over the pericentromeric regions on chromosome 1p 119,360,001-121,186,599, 1q 141,476,958-144,223,174, 19p 23,940,099-24,422,759 and 19q 32,426,023-33,387,097 of the Build 36.1 assembled human genome. In total, the pericentromeric-specific array consist of 4262 (1p), 4556 (1q), 1011 (19p) and 2406 (19q) measurement points of varying repeat/duplication content. In particular, total number of data points comprises 1901 single 100% sequence identity hit probes (128 covering NOTCH2 gene) and these are abbreviated throughout the paper as unique probes. Finally, 1845 positive and negative biological control probes (localized on 1q and 19p and other human autosomes) were included into the array set-up. The designed array provides an average probe spacing of 377 bp. Sample amplification, labeling, and hybridization were performed according to the protocol provided by Agilent Technologies (8x15 K CGH oligonucleotide array-CGH array analyses). Briefly, 500 ng of genomic DNA was digested with AluI and RsaI enzymes followed by column purification (Microcon YM-30, Millipore, Valencia, CA, USA). Digested tumor and reference DNAs were labeled with Cy5-dUTP and Cy3-dUTP, respectively (Genomic DNA labeling Kit Plus, Agilent Technologies, Palo Alto, CA), pooled and hybridized as instructed in the manufacturers protocol. Agilent scanner was used to obtain ratios of Cy5/Cy3 signals from the targets localized on the array. Normalization (dye bias and background correction) and analysis of microarray data was performed using Agilent Feature Extraction (version 9.5.3 Agilent Technologies) and CGH Analytics software's (version 3.4.40, Agilent Technologies), respectively.
###end p 33
###begin title 34
Loss of heterozygosity analysis
###end title 34
###begin p 35
To evaluate allelic loss, a panel of 39 and 42 SNPs (single-nucleotide polymorphisms) on 1p and 1q arm, respectively were studied. The locations and sequences from the LOH-associated SNP loci were retrieved from the database at the National Centre for Biotechnology Information (NCBI) (). Primers flanking these loci were designed using Primer3. Oligonucleotide primer pairs for all SNPs were custom synthesized at MWG Biotech (). Direct sequencing (Big Dye Terminator V3.1) of PCR-amplified locus fragments from blood and tumor DNA samples was carried out by 3130xl Genetic Analyser (Applied Biosystems, Inc.). Results obtained from the SNP loci in blood DNA were used as the baseline to estimate the copy number of the corresponding SNP loci in the tumor DNA. LOH was scored as present when the tumor sample showed reduction in height of one of two peaks (two alleles) by >50%. The consistency of all important results was validated by repeated analysis on both strands.
###end p 35
###begin title 36
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
Mutation analysis of the NOTCH2 gene
###end title 36
###begin p 37
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 310 318 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004107.s002">Table S2</xref>
All 34 NOTCH2 encoding exons (Ensemble: ENSCAFG00000010476) of four selected oligodendroglioma tumor and paired peripheral blood derived DNAs were analyzed for somatic mutations by PCR amplification followed by direct genomic sequencing of both DNA strands (for additional information, see supplementary data, Table S2).
###end p 37
###begin title 38
Supporting Information
###end title 38
###begin p 39
(0.04 MB DOC)
###end p 39
###begin p 40
Click here for additional data file.
###end p 40
###begin p 41
(0.07 MB DOC)
###end p 41
###begin p 42
Click here for additional data file.
###end p 42
###begin p 43
We thank Dr. Jean Soulier for providing the access to Agilent platform and Lucie Hernandez for technical assistance.
###end p 43
###begin title 44
References
###end title 44
###begin article-title 45
###xml 78 83 <span type="species:ncbi:9606">human</span>
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
###end article-title 45
###begin article-title 46
###xml 57 62 <span type="species:ncbi:9606">human</span>
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
###end article-title 46
###begin article-title 47
Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
###end article-title 47
###begin article-title 48
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
###end article-title 48
###begin article-title 49
Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.
###end article-title 49
###begin article-title 50
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.
###end article-title 50
###begin article-title 51
Molecular pathogenesis of oligodendroglial tumors.
###end article-title 51
###begin article-title 52
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
###end article-title 52
###begin article-title 53
Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology.
###end article-title 53
###begin article-title 54
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
###end article-title 54
###begin article-title 55
Two types of chromosome 1p losses with opposite significance in gliomas.
###end article-title 55
###begin article-title 56
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
###end article-title 56
###begin article-title 57
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.
###end article-title 57
###begin article-title 58
###xml 100 108 <span type="species:ncbi:9606">patients</span>
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
###end article-title 58
###begin article-title 59
Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.
###end article-title 59
###begin article-title 60
###xml 60 65 <span type="species:ncbi:9606">human</span>
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors.
###end article-title 60
###begin article-title 61
F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation.
###end article-title 61
###begin article-title 62
Notch1 and notch2 have opposite effects on embryonal brain tumor growth.
###end article-title 62
###begin article-title 63
BAC microarray analysis of 15q11-q13 rearrangements and the impact of segmental duplications.
###end article-title 63
###begin article-title 64
###xml 46 51 <span type="species:ncbi:9606">human</span>
The DNA sequence and biological annotation of human chromosome 1.
###end article-title 64
###begin article-title 65
###xml 32 37 <span type="species:ncbi:9606">human</span>
The DNA sequence and biology of human chromosome 19.
###end article-title 65
###begin article-title 66
###xml 73 78 <span type="species:ncbi:9606">human</span>
The structure and evolution of centromeric transition regions within the human genome.
###end article-title 66
###begin article-title 67
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
###end article-title 67
###begin article-title 68
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.
###end article-title 68
###begin article-title 69
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human alphoid DNA clone from the EcoRI dimeric family: genomic and internal organization and chromosomal assignment.
###end article-title 69
###begin article-title 70
Breakpoints in Robertsonian translocations are localized to satellite III DNA by fluorescence in situ hybridization.
###end article-title 70
###begin article-title 71
A further whole arm 1;19 translocation with alpha-satellite DNA breakage.
###end article-title 71
###begin article-title 72
Balanced reciprocal whole arm translocation t(3;9): analysis by fluorescence in situ hybridisation.
###end article-title 72
###begin article-title 73
A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency.
###end article-title 73
###begin article-title 74
DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements.
###end article-title 74
###begin article-title 75
###xml 31 36 <span type="species:ncbi:9606">human</span>
Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.
###end article-title 75
###begin article-title 76
###xml 51 56 <span type="species:ncbi:9606">human</span>
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment.
###end article-title 76
###begin article-title 77
Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.
###end article-title 77
###begin article-title 78
###xml 87 92 <span type="species:ncbi:9606">human</span>
Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.
###end article-title 78
###begin article-title 79
###xml 162 167 <span type="species:ncbi:9606">human</span>
Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas.
###end article-title 79
###begin article-title 80
Satellite DNA hypomethylation in karyotyped Wilms tumors.
###end article-title 80
###begin p 81
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 81
###begin p 82
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Magdalena Benetkiewicz is supported by a fellowship from Canceropole Ile-de-France. This work was supported by grants from the INCa, the INSERM and the Ligue Nationale Contre le Cancer (Equipe Labellisee). The BAC-array was supported by grant from the Carte d'Identite des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer.
###end p 82

